Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Zipoli

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Journal of Translational Medicine|April 20, 2011
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patientsValentina Durastanti, Alessandra Lugaresi, Placido Bramanti, et al.
Journal of Neuroimmunology|July 30, 2005
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosisFrancesco Lolli, Benedetta Mazzanti, Marta Pazzagli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2012
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in ItalyPietro Annovazzi, Valentina Tomassini, Benedetta Bodini, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Multiple Sclerosis and Related Disorders|February 3, 2020
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patientsGiulia Mallucci, Francesco Patti, Vincenzo Brescia Morra, et al.
Journal of Translational Medicine|April 20, 2011
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patientsValentina Durastanti, Alessandra Lugaresi, Placido Bramanti, et al.
Journal of Neuroimmunology|July 30, 2005
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosisFrancesco Lolli, Benedetta Mazzanti, Marta Pazzagli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2012
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in ItalyPietro Annovazzi, Valentina Tomassini, Benedetta Bodini, et al.
Pageof 4